13, 14-epoxyoleanan-3-ol-acetate | 180 |
32 factorial design | 125 |
3T3-NRU phototoxicity test | 70 |
5-fluorouracil | 371 |
ABTS | 287 |
Acceptability of vaccine | 686 |
Acetylcholinesterase | 377 |
Activated partial thromboplastin time | 330 |
Acute myeloid leukemia | 314 |
ADHD | 251 |
Adipocytokines | 48 |
ADMET | 202 |
Adverse drug reaction reporting system | 694 |
Adverse drug reactions | 280 |
Adverse reactions of the skin | 610 |
Aegle marmelos | 168 |
Agrimonia eupatoria | 498 |
AGS cells | 239 |
Almond gum | 521 |
Alpha-lipoic acid | 196 |
Aluminum | 618 |
Amaranthus albus | 498 |
Analgesics | 583 |
Analytic hierarchy process | 701 |
Analytical method | 589 |
Anemia | 603 |
Anti-aging | 400 |
Anti-hyperalgesic | 336 |
Antibacterial activity | 145 |
Antibiotic resistance | 681 |
Antibiotics | 447 |
Anticonvulsant | 595 |
Antidepressant | 336 |
Antidiabetic | 377 |
Antidiabetic activity | 353 |
Antigenic | 649 |
Antimicrobial peptide | 110 |
Antimicrobial resistance | 447 |
Antioxidant | 377 |
Antioxidant activity | 287 |
Antioxidants | 28, 76400 |
Antioxidative activity | 76 |
Antiperspirant products | 618 |
Antiviral natural compounds | 93 |
Apis dorsata honey | 246 |
Apoptosis | 314, 371 |
Application | 706 |
Application of proniosome | 462 |
Aromatase inhibition | 626 |
Asthma | 35 |
Atazanavir sulfate | 408 |
Atropa | 442 |
Azithromycin | 101 |
BALB/c 3T3 cells | 70 |
BBD | 9 |
BCS class II | 168 |
Behavior | 694 |
Bilirubin | 116 |
Binder | 513 |
Bio/mucoadhesive system | 476 |
Bioavailability | 63, 476, 706 |
Bioelement | 76 |
Bioequivalence | 706 |
Bionanocomposite | 168 |
Biopharmaceutical classification system | 706 |
Blank subtraction method | 530 |
Borax | 371 |
Brain-derived neurotrophic factor | 196 |
Brain-targeting | 560 |
Britannin | 314 |
Bulk and dosage forms | 213 |
Butyrylcholinesterase | 377 |
Calcium | 161 |
Caprifoliaceae | 636 |
Cardiac markers | 28 |
Cardiac toxicity | 138 |
Cardioprotection | 28 |
Cardiotoxicity | 1, 28, 132 |
Caulerpa racemosa | 116 |
CCD | 9 |
Cefdinir | 530 |
Cell-based assay | 626 |
Cell-free assay | 626 |
Chenopodium album | 498 |
Chitosan | 671 |
Chitosan gold nanoparticles | 391 |
Chromophores | 220 |
Chronic kidney disease | 305 |
Chronic myeloid leukemia | 314 |
Chronic wound | 187 |
Cinnarizine | 19 |
Ciprofloxacin hydrochloride | 293 |
Cisplatin | 132, 505 |
Citicoline | 505 |
Classification | 543 |
Clear permeability | 63 |
Clinical pharmacist | 54 |
Co-crystals | 220 |
Coagulation cascade | 330 |
Coating | 153 |
Cocrystallization | 220 |
Colorectal adenocarcinoma | 371 |
Column chromatography | 630 |
Combination | 110 |
Community pharmacists | 280 |
COPD (chronic obstructive pulmonary diseases) | 35 |
Corona | 93 |
Corticosteroid | 101 |
Cosmetic | 220 |
Cosmetic regulations | 610 |
Cosmetovigilance | 610 |
Costaceae | 145 |
Costus pictus | 145 |
Costus speciosus | 145 |
COVID-19 | 101, 202, 232, 416, 431, 686 |
COVID-19 pandemic | 657 |
Creatine | 196 |
Curcumin | 560 |
Cyclosporine | 196 |
Cytotoxic effects | 314 |
Cytotoxicity | 84, 187, 642 |
Cytotoxicity and cellular uptake | 391 |
Daidzein | 84 |
Datura | 442 |
Depression | 196 |
Dexamethasone | 505 |
Diabetes | 630 |
Diabetes mellitus | 630 |
Diabetes mellitus type-2 | 161 |
Digital image colorimetry | 618 |
Diospyros lotus | 132 |
Disintegrant | 513 |
Dispersible tablet | 383 |
Dissolution | 706 |
Dissolution behavior | 408 |
Divalproex sodium | 422 |
DLD-1 | 371 |
Documentation | 543 |
Doxorubicin | 28, 138 |
Doxycycline | 101 |
DPPH | 287 |
Drug design | 93, 353 |
Drug disposition | 706 |
Drug interactions | 543 |
Drug solubility | 706 |
Drug-related impurities | 293 |
Dry powder inhaler | 35 |
Ekici & Dönmez | 76 |
Empower 3 software | 530 |
Endometriosis | 48 |
Endophyte | 630 |
Enzyme inhibitory activity | 76 |
Epitope | 649 |
Essential oil | 76 |
Ethnomedicine | 714 |
Ethyl acrylate-methyl methacrylate copolymers | 383 |
Eudragit L 100-55 | 125 |
Eutectic | 220 |
Evaluation of proniosome | 462 |
Ex vivo permeation studies | 572 |
Excipient | 513 |
Extended release | 125 |
Extra virgin olive oil | 138 |
Extremely drug resistance | 447 |
Faculty websites | 666 |
Fatty acids | 273, 322, 442 |
Flavonoids | 202 |
Forced degradation study | 35 |
FTIR analysis | 84 |
Gamma-cyclodextrin | 408 |
Gas chromatography | 442 |
Gas chromatography-mass spectrometry | 273, 322 |
Gastric cancer | 239 |
Gastric emptying | 476 |
Gastroretentive | 595 |
GC-MS/MS | 455 |
Gelucire (43/01) | 521 |
Gemini curcumin | 239 |
Gene therapy/delivery | 104 |
Genotoxic impurity | 455 |
Glutathione | 116 |
Glycemic control | 161 |
Gomphandra tetrandra | 583 |
Hansen parameters parameter | 168 |
Helichrysum compactum | 498 |
Hepcidin | 603 |
Herbal medicines | 280 |
Herbal products | 280 |
Herniaria glabra tablets | 153 |
Higuchi diffusion kinetics | 572 |
Histochemical | 145 |
Hospital pharmacist | 232 |
Hospital pharmacy | 232 |
Hot plate | 336 |
HPLC | 267, 293, 636 |
HPMC | 153, 251 |
HPMC K100M | 125 |
HPTLC | 400 |
Hyoscyamus | 442 |
ICH and validation | 488 |
ICH guidelines | 35 |
Immune-enhancers | 701 |
In situ gels | 671 |
In vitro | 626 |
In vitro lipid peroxidation assay | 180 |
In vitro phototoxicity | 70 |
Indatraline | 336 |
Infection | 686 |
Inflammation | 48 |
Influenza A virus interferon response | 552 |
Influenza RdRP | 552 |
Inhibitory activity | 630 |
Intranasal delivery | 560 |
Iron deficiency | 603 |
Ivermectin | 101 |
Kidney | 116 |
Knowledge | 694 |
LC-MS/MS | 630 |
Lentinus squarrosulus | 642 |
Lentivirus | 104 |
Lepidium sativum | 714 |
Leydig cells | 246 |
Lipase | 642 |
Lipid peroxidation | 1, 116 |
lnc-CCAT2 and c-Myc | 239 |
LOD & LOQ determination | 35 |
Lonicera etrusca var. etrusca | 636 |
Low-income countries | 232 |
Maclura pomifera | 400 |
Maize starch | 513 |
Maltodextrin | 251 |
Matrix type drug delivery | 572 |
MBTH | 9 |
MCF-7 cell line and Caco-2 cell line | 391 |
MDA | 246 |
Media milling | 84 |
Medicinal plants | 330, 714 |
Melt granulation | 422 |
Ménière’s disease | 19 |
Metastasis | 239 |
Methanolic extract | 583 |
Metoclopramide | 589 |
Microemulsion | 560 |
Microparticle hydrogel | 187 |
Microspheres | 595 |
Microwave-assisted fusion method | 168 |
MMEC | 560 |
Moisture protection | 153 |
Molecular docking | 93, 431 |
Momordica charantia | 180 |
Moringa oliefera | 168 |
Motion sickness | 19 |
Motor and non-motor fluctuations | 343 |
Mouth dissolving film | 251 |
MSG | 246 |
Mucoadhesion | 560 |
Multidrug resistance | 447 |
n-hexane fraction | 180 |
N-nitrosamine | 455 |
Nanoparticle solubility | 408 |
Nanosuspension | 84 |
National accreditation | 666 |
Natural compounds | 93 |
Necrosis | 246 |
Neocarya macrophylla | 202 |
Nephrotoxicity | 1 |
Nerolidol | 1 |
Neuropathic pain | 336 |
New drug | 706 |
Nigeria | 447, 686 |
Ninhydrin | 9 |
Non-cytotoxic | 110 |
Non-fickian diffusion | 125 |
Novel indole derivative | 63 |
nsp10-nsp16 protein complex | 93 |
Nutraceutical | 714 |
Obesity | 498 |
Ocular infections | 671 |
Olaparib | 488 |
Older adults | 54, 305 |
Oncology | 505 |
Optimized transdermal patch | 572 |
Oral and non-oral treatment | 343 |
Orlistat | 168 |
Orthosiphon stamineus | 671 |
Osajin | 400 |
Outpatients | 54 |
Oxidative stress | 132 |
Padina pavonia | 116 |
Pandemic anxiety | 657 |
Parkinson’s disease | 343 |
Passiflora incarnata | 287 |
PCR array | 552 |
Pellets | 521 |
Penetration enhancers | 19 |
Peptide hormone | 603 |
Peripheral neuropathy | 505 |
Permeability glycoprotein | 63 |
Peroxisome proliferator-activated receptors | 353 |
Pharmacist | 232, 701 |
Pharmacists | 694 |
Pharmacovigilance | 694 |
Pharmacy education | 666 |
Pharmacy school | 666 |
Pharmacy schools | 657 |
Pharmacy service | 232 |
Phototoxicity | 70 |
Phytochemical profile | 287 |
Phytovigilance | 280 |
Pili protein | 649 |
Plant anatomy | 636 |
Poloxamer | 671 |
Poly ADP-ribose polymerase (PARP) inhibitor | 488 |
Polypharmacy | 54 |
Population health | 543 |
Potato starch | 513 |
Potentially inappropriate medication use | 305 |
Proniosomes | 462 |
Prothrombin time | 330 |
Prunus dulcis | 322 |
Pseudomonas aeruginosa | 447 |
Psychological well-being | 657 |
Pycnamine | 431 |
ɸAB140 and ɸAB150 phage | 187 |
Quality control | 273, 322 |
Quality control laboratories | 267 |
Quality of life | 161 |
Quercetin | 618 |
Rabbit | 595 |
Racecadotril | 383 |
Radical scavenging activity | 287 |
Radiographic | 595 |
Ranolazine | 125 |
Remogliflozin etabonate | 213 |
Reproductive health | 246 |
Resistant bacteria | 110 |
Resveratrol | 104 |
Risk perception | 686 |
Rosuvastatin | 28 |
RP-HPLC | 213, 488 |
RP-HPLC-UV | 530 |
Rufinamide | 267 |
Safety of herbal medicines | 280 |
Safflower oil | 273 |
Salt resistant | 110 |
Salts | 220 |
SARS-CoV-2 | 93, 202 |
Saxagliptin | 9 |
Sciatic nerve ligation | 336 |
Science laboratory surfaces | 681 |
Secondary metabolites | 630 |
Seconder metabolites | 431 |
Sedative-hypnotic activity | 583 |
Shellac | 153 |
Shigella flexneri | 649 |
Side effects of cosmetics | 610 |
Sideritis akmanii Aytaç | 76 |
Simplex centroid design | 251 |
Skin permeation | 19 |
Smartphone | 618 |
Smoking behaviors | 416 |
Sodium benzoate | 530 |
Software | 543 |
Solid dispersion | 422 |
Specified | 293 |
Spectrophotometric methods | 530 |
Spectrophotometry | 589 |
Spheronization | 521 |
STOPP/START criteria | 54 |
Structure-activity relationship | 353 |
Sustain release | 422 |
Sustained release | 521 |
Synergism | 110 |
Tablet | 513 |
Tail flick | 336 |
Talsupram | 336 |
Tamoxifen citrate and β-cyclodextrin | 391 |
Tanacetum argyrophyllum var. argyrophyllum | 377 |
Taste-masking | 383 |
Tattoo ink | 70 |
TEM | 560 |
Therapeutic agents | 714 |
Therapeutic window | 476 |
Thiazolidinediones | 353 |
Thioacetamide | 1 |
Titrimetry | 589 |
TLC | 293 |
Tramadol hydrochloride | 572 |
Türkiye | 416, 636 |
University students | 416 |
UV spectroscopy | 213 |
UV-visible spectrophotometry | 267 |
Validation | 267 |
Valsartan | 455 |
Vesicular drug delivery | 462 |
Vilazodone | 336 |
Viral vectors | 104 |
Virgin coconut oil | 138 |
Vitamin D | 161 |
Vitamin E | 180 |
VLC | 180 |
Waters | 488 |
Wet granulation | 383 |
Whole genome sequencing | 681 |
WLBU2 | 110 |
Xcelligence RTCA systems | 391 |
α-Amylase | 642 |
α-Glucosidase | 642 |